Title : Gastrointestinal peptides and nonalcoholic fatty liver disease.

Pub. Date : 2020 Feb

PMID : 31815784






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RECENT FINDINGS: Recent approaches, in animal models or in humans, use synthetic GLP-1 receptor agonists, a centrally administered antibody neutralizing GIP receptor, curcumin, compound being active on nesfatin, resveratrol (antiinflammatory agent), and Ginseg, both of them acting on nesfatin, a cholecystokinin receptor analogue, and finally coffee functioning on YY peptide. Cholecystokinin glucagon like peptide 1 receptor Homo sapiens